HK1042490A1 - A process for the preparation of taxanes from 10-deacetylbaccatin iii - Google Patents

A process for the preparation of taxanes from 10-deacetylbaccatin iii

Info

Publication number
HK1042490A1
HK1042490A1 HK02104134A HK02104134A HK1042490A1 HK 1042490 A1 HK1042490 A1 HK 1042490A1 HK 02104134 A HK02104134 A HK 02104134A HK 02104134 A HK02104134 A HK 02104134A HK 1042490 A1 HK1042490 A1 HK 1042490A1
Authority
HK
Hong Kong
Prior art keywords
preparation
deacetylbaccatin iii
taxanes
groups
hydrolysis
Prior art date
Application number
HK02104134A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1042490A1 publication Critical patent/HK1042490A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Seasonings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02104134A 1999-03-02 2002-05-31 A process for the preparation of taxanes from 10-deacetylbaccatin iii HK1042490A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000417A IT1308636B1 (it) 1999-03-02 1999-03-02 Procedimento per la preparazione di tassani da 10-desacetilbaccatinaiii.
PCT/EP2000/001471 WO2000052003A1 (en) 1999-03-02 2000-02-23 A process for the preparation of taxanes from 10-deacetylbaccatin iii

Publications (1)

Publication Number Publication Date
HK1042490A1 true HK1042490A1 (en) 2002-08-16

Family

ID=11382101

Family Applications (2)

Application Number Title Priority Date Filing Date
HK02104134A HK1042490A1 (en) 1999-03-02 2002-05-31 A process for the preparation of taxanes from 10-deacetylbaccatin iii
HK04108044A HK1065309A1 (en) 1999-03-02 2004-10-18 Intermediates for the preparation of taxane derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK04108044A HK1065309A1 (en) 1999-03-02 2004-10-18 Intermediates for the preparation of taxane derivatives

Country Status (23)

Country Link
US (2) US6500966B1 (no)
EP (1) EP1157018B1 (no)
JP (1) JP2002538155A (no)
KR (1) KR100660663B1 (no)
CN (2) CN1295223C (no)
AT (1) ATE231499T1 (no)
AU (1) AU759566B2 (no)
BR (1) BR0008633A (no)
CA (1) CA2361187C (no)
CZ (1) CZ301702B6 (no)
DE (1) DE60001265T2 (no)
DK (1) DK1157018T3 (no)
ES (1) ES2189747T3 (no)
HK (2) HK1042490A1 (no)
HU (1) HU229346B1 (no)
IL (1) IL145216A0 (no)
IT (1) IT1308636B1 (no)
NO (1) NO327909B1 (no)
PL (1) PL195906B1 (no)
PT (1) PT1157018E (no)
RU (1) RU2233276C2 (no)
SK (1) SK286880B6 (no)
WO (1) WO2000052003A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318678B1 (it) * 2000-08-10 2003-08-27 Indena Spa Procedimento per la preparazione di derivati della baccatina iii.
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
CN1303077C (zh) * 2004-01-16 2007-03-07 桂林晖昂生化药业有限责任公司 合成紫杉烷的制备工艺
EP1647552A1 (en) * 2004-10-08 2006-04-19 INDENA S.p.A. Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
EP1712552A1 (en) * 2005-04-11 2006-10-18 INDENA S.p.A. Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
US7446126B2 (en) * 2004-10-08 2008-11-04 Indena S.P.A. Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
ITMI20050614A1 (it) * 2005-04-12 2006-10-13 Indena Spa Processo per la purificazione della 10-deacetilbaccatina iii dalla 10-deacetil-2-debenzoil-2-pentenoilbaccatina iii
KR101009467B1 (ko) 2006-03-13 2011-01-19 주식회사 셀트리온화학연구소 도세탁셀의 합성에 유용한 탁산 유도체 및 그 제조방법
KR100847331B1 (ko) * 2006-12-14 2008-07-21 한미약품 주식회사 도세탁셀의 제조방법 및 이에 사용되는 중간체
ITMI20062479A1 (it) * 2006-12-21 2008-06-22 Indena Spa Processo per la preparazione di secotassani
JP4833126B2 (ja) * 2007-03-26 2011-12-07 Ｎｔｎ株式会社 潤滑剤劣化検出装置および検出装置付き軸受
WO2011134067A1 (en) * 2010-04-29 2011-11-03 6570763 Canada Inc. Novel amino acid molecule and uses thereof
WO2016098015A1 (en) * 2014-12-16 2016-06-23 Khashayar Karimian New efficient methods for the synthesis of taxane derivatives such as docetaxel and their structural analogous, and a method for the preparation thereof
CN107056767B (zh) * 2015-12-04 2022-07-15 江苏恩华络康药物研发有限公司 用于制备水溶性紫杉烷类衍生物的方法及中间体
CN115232092A (zh) * 2022-05-19 2022-10-25 无锡紫杉药业有限公司 一种10-乙酰多西他赛的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE34277E (en) 1988-04-06 1993-06-08 Centre National De La Recherche Scientifique Process for preparing taxol
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5990325A (en) 1993-03-05 1999-11-23 Florida State University Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
FR2696460B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
CN1073105C (zh) * 1994-07-26 2001-10-17 因迪纳有限公司 具有抗肿瘤活性的半合成紫杉烷
JP2964475B2 (ja) * 1994-11-17 1999-10-18 田辺製薬株式会社 バッカチン誘導体及びその製法
GB9512471D0 (en) * 1995-06-20 1995-08-23 Pharmacia Spa Method for the preparation of taxol and its derivatives
KR100225535B1 (ko) * 1996-08-27 1999-10-15 정지석 파클리탁셀의 제조방법
US7288665B1 (en) * 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes

Also Published As

Publication number Publication date
AU759566B2 (en) 2003-04-17
PT1157018E (pt) 2003-06-30
CA2361187A1 (en) 2000-09-08
EP1157018B1 (en) 2003-01-22
IT1308636B1 (it) 2002-01-09
RU2233276C2 (ru) 2004-07-27
JP2002538155A (ja) 2002-11-12
WO2000052003A1 (en) 2000-09-08
CZ301702B6 (cs) 2010-06-02
CZ20013146A3 (cs) 2002-01-16
KR100660663B1 (ko) 2006-12-21
CN1133632C (zh) 2004-01-07
BR0008633A (pt) 2001-12-26
EP1157018A1 (en) 2001-11-28
AU3806000A (en) 2000-09-21
NO327909B1 (no) 2009-10-19
CN1502614A (zh) 2004-06-09
PL195906B1 (pl) 2007-11-30
HUP0302750A2 (hu) 2003-12-29
ES2189747T3 (es) 2003-07-16
DE60001265D1 (de) 2003-02-27
US6500966B1 (en) 2002-12-31
CN1295223C (zh) 2007-01-17
NO20014211L (no) 2001-08-30
HU229346B1 (en) 2013-11-28
IL145216A0 (en) 2002-06-30
ITMI990417A1 (it) 2000-09-02
NO20014211D0 (no) 2001-08-30
CN1342154A (zh) 2002-03-27
SK286880B6 (sk) 2009-07-06
CA2361187C (en) 2009-01-27
DE60001265T2 (de) 2003-08-28
SK12262001A3 (sk) 2001-12-03
ATE231499T1 (de) 2003-02-15
HUP0302750A3 (en) 2005-02-28
HK1065309A1 (en) 2005-02-18
DK1157018T3 (da) 2003-05-05
KR20010102444A (ko) 2001-11-15
USRE40120E1 (en) 2008-02-26

Similar Documents

Publication Publication Date Title
HK1042490A1 (en) A process for the preparation of taxanes from 10-deacetylbaccatin iii
HU0203995D0 (en) Oxazole derivatives for synthesis of sidechain-bearing taxanes and preparation thereof
NO981823D0 (no) Mellomprodukter for hemisyntese av taxaner og fremstilling derav
AU2328092A (en) Process for the preparation of baccatin iii and 10-deacetyl baccatin iii derivatives
HUP0202448A2 (hu) Eljárás paclitaxel C-4-metil-karbonát-analóg előállítására
SI1114815T1 (en) Process to prepare taxol
HK1042301A1 (en) Semi-synthesis of paclitaxel using dialkyldichlorosilanes
NO955112L (no) Fremgangsmåte for fremstilling av oksazolidinkarboksylsyre samt anvendelse derav for fremstiling av terapeutisk aktive taxoider
DK0663901T3 (da) Fremgangsmåde til stereoselektiv fremstilling af et derivat af beta-phenylisoserin samt anvendelse deraf til fremstilling af taxanderivater
ES2285967T1 (es) Procedimiento para elaborar derivados de taxano.
SI2298754T1 (sl) Priprava derivatov taksana
TW200743653A (en) Polymer comprising organic silicon compound and boron compound

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190223